Trupanion, Inc. (NASDAQ:TRUP) COO John R. Gallagher Sells 3,100 Shares

Trupanion, Inc. (NASDAQ:TRUP) COO John R. Gallagher sold 3,100 shares of the firm’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $102,269.00. Following the transaction, the chief operating officer now directly owns 25,549 shares of the company’s stock, valued at $842,861.51. The trade was a 10.82 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Trupanion Trading Down 1.5 %

Shares of NASDAQ TRUP opened at $33.58 on Friday. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The business’s 50 day moving average is $42.92 and its two-hundred day moving average is $47.14. The stock has a market capitalization of $1.43 billion, a P/E ratio of -146.00, a PEG ratio of 6.02 and a beta of 1.70.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on TRUP. Piper Sandler cut their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Stifel Nicolaus cut their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Trupanion has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.

Institutional Investors Weigh In On Trupanion

Several institutional investors have recently made changes to their positions in TRUP. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Trupanion by 14.2% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 89,184 shares of the financial services provider’s stock worth $4,299,000 after purchasing an additional 11,119 shares during the period. Squarepoint Ops LLC lifted its holdings in Trupanion by 32.5% during the 4th quarter. Squarepoint Ops LLC now owns 211,900 shares of the financial services provider’s stock valued at $10,214,000 after buying an additional 52,031 shares in the last quarter. State of Wyoming lifted its holdings in Trupanion by 111.4% during the 4th quarter. State of Wyoming now owns 11,158 shares of the financial services provider’s stock valued at $538,000 after buying an additional 5,880 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in Trupanion in the 4th quarter valued at about $347,000. Finally, Raiffeisen Bank International AG bought a new position in Trupanion in the 4th quarter worth about $2,505,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.